Plain-English translation of NCT02803970 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Neoplasms research guide →Researchers are building a database of medical information from Korean patients who have been diagnosed with borderline ovarian tumors—tumors of the ovary that are not quite cancerous but need careful monitoring. By collecting data from both past patients (since 1994) and new patients going forward, the researchers hope to learn more about these tumors, including how they respond to different treatments and what happens to patients over the long term.
Borderline ovarian tumors are uncommon and not well understood. By gathering information from many patients in one database, researchers can identify patterns in how these tumors behave, who is at higher risk, and what treatments work best—ultimately helping doctors care for future patients more effectively.
You likely qualify if…
You likely don't qualify if…
If you join, your medical information will be added to a research database—this includes your age, imaging results, surgery details, pathology findings, and how you've done after treatment. Researchers will update your information every 6 months with news about your recovery and any follow-up visits. Most information comes directly from your medical records, though researchers may contact you if they need additional details that aren't already documented.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
South Korea
Sponsor
Kangbuk Samsung Hospital
Enrollment target
~3,000 participants
Started
December 1994
Primary completion
December 2040
Sex
Female only
Last updated on clinicaltrials.gov in April 2019.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Taejong Song, MD,PhD
Kangbuk Samsung Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.